PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • Sustainability
  • Investor Relations
  • Newsroom

About Us

About PHC GroupCEO MessageMission, Vision & ValuesValue Creation PlanHistory LeadershipPHC Group by the Numbers

Group Companies

Ascensia LSI Medience Wemex Mediford Epredia PHCbi PHC IVD

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

Sustainability

Sustainability
  • CEO Message
  • Materiality
  • Sustainability Management
  • PHC GROUP Integrated Report
  • Stakeholder Engagement
  • Environment image
    Environment
  • Society image
    Social
  • Governance image
    Governance

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy
  • Business Risks

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials
  • Historical Financial Data
  • PHC GROUP Integrated Report
  • Mid-term Plan
  • Our Group Introduction

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Shareholder Newsletter
  • Stock Quotations
  • Analyst Coverage
IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom

NEWSROOM

NEWS

  • PHC Holdings Corporation
  • PHC Group Companies
CareersContact
JP

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation
CareersContactJP
Newsroom > 2021 > Site Reopening in Response to Partial Lifting of COVID-19 Imposed State of Emergency

News


2021

AnnouncementSeptember 10

Site Reopening in Response to Partial Lifting of COVID-19 Imposed State of Emergency

Our sincere condolences to victims of COVID-19, and we hope for the quick recovery of those who have been infected. We also offer sincere gratitude towards healthcare professionals on the forefront to treat patients, and everyone helping to support the community infrastructure.

Responding to the Japanese Government’s decision to lift the state of emergency in two prefectures, PHC Holdings Corporation (headquarters: Tokyo, Japan) will be reopening the following company site from September 13. However, as we prioritize the safety of customers and employees, employees of the reopening site will continue to work from home in principle.

● Site reopening

PHC Corporation Biomedical Business Unit
 ・Tohoku Sales Office
   Address: Sendai Capital Tower 4F, 4-10-3 Chuo, Aoba-ku, Sendai City, Miyagi

The health and safety of our customers, patients, employees and their families are most important to us and we will continue to further strengthen measures to prevent internal and external spread of the infection, while working to ensure stable supply for customers and patients who rely on our products and services.

Media contact

Corporate Communications Dept.
PHC Holdings Corporation
+81-3-6778-5311

  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.